{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:29:31Z","timestamp":1783582171190,"version":"3.55.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Among solid organ transplant recipients taking belatacept, 15% developed invasive fungal diseases. The most common invasive fungal diseases were aspergillosis (56%) and candidiasis (22%). The infected cohort was more likely to receive basiliximab, undergo lung transplantation, or identify as White. Higher rates of aspergillosis were seen in this lung cohort than previously reported.<\/jats:p>","DOI":"10.1093\/ofid\/ofae158","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T15:20:03Z","timestamp":1710602403000},"source":"Crossref","is-referenced-by-count":10,"title":["An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-075X","authenticated-orcid":false,"given":"Elizabeth","family":"Bell","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases and Global Health, University of Chicago Medical Center , Chicago, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pisano","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Global Health, University of Chicago Medical Center , Chicago, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Chicago Medical Center , Chicago, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-7454","authenticated-orcid":false,"given":"Daniel","family":"Friedman","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Global Health, University of Chicago Medical Center , Chicago, Illinois , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"key":"2024061711530643200_ofae158-B1","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1016\/B978-1-4557-4801-3.00313-1","volume-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","author":"Singh","year":"2015","edition":"8th ed"},{"key":"2024061711530643200_ofae158-B2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024061711530643200_ofae158-B3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"2024061711530643200_ofae158-B4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"issue":"12)","key":"2024061711530643200_ofae158-B5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.ekir.2023.08.037","article-title":"Costimulatory blockade and solid organ transplantation: the past, present, and future.","volume":"8","author":"Kitchens","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2024061711530643200_ofae158-B6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/ajt.12810","article-title":"Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study.","volume":"14","author":"Klintmalm","year":"2014","journal-title":"Am J Transplant"},{"key":"2024061711530643200_ofae158-B7","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1111\/ajt.16113","article-title":"Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition.","volume":"20","author":"Alishetti","year":"2020","journal-title":"Am J Transplant"},{"key":"2024061711530643200_ofae158-B8","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1681\/ASN.2021050628","article-title":"Conversion from calcineurin inhibitor- to belatacept-based maintenance immunosuppression in renal transplant recipients: a randomized phase 3b trial.","volume":"32","author":"Budde","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2024061711530643200_ofae158-B9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","article-title":"Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.","volume":"12","author":"Medina Pestana","year":"2012","journal-title":"Am J Transplant"},{"key":"2024061711530643200_ofae158-B10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients: belatacept in CNI- and steroid-avoiding regimens","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"2024061711530643200_ofae158-B11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.transproceed.2016.01.003","article-title":"Invasive tracheobronchial aspergillosis in a lung transplant recipient receiving belatacept as salvage maintenance immunosuppression: a case report","volume":"48","author":"Haidar","year":"2016","journal-title":"Transplant Proc"},{"key":"2024061711530643200_ofae158-B12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ajt.17028","article-title":"A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation.","volume":"22","author":"Huang","year":"2022","journal-title":"Am J Transplant"},{"key":"2024061711530643200_ofae158-B13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and efficacy outcomes 3 years after switching to belatacept from a calcineurin inhibitor in kidney transplant recipients: results from a phase 2 randomized trial","volume":"69","author":"Griny\u00f3","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2024061711530643200_ofae158-B14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2024061711530643200_ofae158-B15","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"2024061711530643200_ofae158-B16","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024061711530643200_ofae158-B17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2024061711530643200_ofae158-B18","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae158\/56994628\/ofae158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae158\/58234250\/ofae158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/6\/ofae158\/58234250\/ofae158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:53:33Z","timestamp":1718625213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae158\/7630414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae158","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,16]]},"article-number":"ofae158"}}